The program aims to provide rigour and excellence in laboratory and clinical research training to the next generation of clinical researchers.
From the laboratory perspective, we will continue to train PhD and honours students through university academic programs, and to mentor postdoctoral researchers to develop into independent scientists. We will disseminate the wide range of experimental techniques and model systems that are used in this program to train the next generation of molecular neuroscientists.
From the clinical perspective, we propose to expand the current personnel by supporting clinical fellows, provide for PhD scholarship stipends, in addition to funding a dedicated clinical research neuropsychologist, occupational therapist, speech pathologist, clinical nurse specialist, exercise physiologist and database manager. As such, the program will train clinical researchers and will facilitate development of career paths that encompass integrated neuroscience and clinical skills. This strategy will ensure an emerging cohort of clinician researchers who can facilitate translation of neuroscience findings into clinical practice and, importantly, optimise public health benefits by disseminating most recent evidence-based practice to community settings. Each clinician researcher will be trained in an interdisciplinary culture, co-supervised by investigators with different areas of expertise, thereby promoting integration of diverse approaches.
Prof Kril has academic expertise in research student training (Assoc Dean, Postgraduate Studies, Sydney Medical School) and will take prime responsibility for developing and overseeing training and mentoring within the program with the remit to substantially grow our capacity in this area.
For more information on how to get involved with either the clinical or laboratory based research please contact firstname.lastname@example.org.
One in every 100 Australians lives with schizophrenia. No single cause of schizophrenia has been identified, and this has prevented the development of a cure. Current schizophrenia treatments are designed to suppress symptoms rather than target underlying causes of the disorder, only partially relieving these symptoms and can produce unwanted side effects. But now, in a breakthrough study from Professor […]